Tag: Relievant
Boston Scientific expands neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous...
Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...
Relievant announces publication of Level I SMART study data
Relievant Medsystems has announced the publication of long-term data from the Level I SMART trial showing durability of improvements in pain and function beyond...
Relievant announces publication of Level I INTRACEPT study
Relievant Medsystems recently announced the publication of the Level I INTRACEPT Study results in The Spine Journal. The INTRACEPT Study is a Level I,...
Relievant announces publication of SMART trial 24-month results
Relievant Medsystems have announced the publication of 24-month results from the SMART trial in the International Journal of Spine Surgery. A total of 106...